About
With increasing healthcare costs and decreasing numbers of healthcare professionals, the application of technology to healthcare has become essential. Technological developments are increasing at a rapid rate and digital innovations are steadily making their way into everyday clinical practice. This means that the skills that new professionals are required to maser are rapidly transforming not just the healthcare curriculum, but also the way healthcare institutions function and care pathways they provide. In addition, assessing the feasibility, viability and cost-effectiveness of new approaches is often a challenging and daunting process, which needs to be approached in a scholarly fashion.
The Research Group for Innovation, Health Economics and Digital Transformation at the Germans Trias i Pujol Research Institute was set up in early 2022; it brings together specialists in a number of different areas. The overarching aim of the group is to conduct applied transversal research with the vision of impacting the healthcare model, it will do this by connecting multidisciplinary teams, consisting of management, innovation, digital transformation, knowledge transfer and health economics experts.
Keywords: Innovation, health economics, digital health, digital transformation, processes, healthcare, research.
_1686566786.jpg)
Group leader
- Oriol Estrada Cuxart, PhD, FHEA
Oriol Estrada Cuxart, PhD, FHEA
Oriol Estrada Cuxart, a University of Barcelona medicine graduate (1987) and internal medicine specialist, boasts a distinguished career enriched by a PhD in Clinical Innovation from Universitat Autònoma de Barcelona, focusing on home endovenous treatments for serious infections. Further honing his expertise, he earned a diploma in Integrated Health Services Management from ESADE Business School in 2011. Estrada has since ascended to prominent leadership roles in healthcare, notably spearheading health strategy and innovation in Catalonia's North Metropolitan Area, impacting over 1.5 million residents through his leadership in over 100 integration and innovation projects.
Estrada's expertise centers on clinical innovation, driving significant improvements in care and health outcomes. He initiated a pioneering technological innovation program addressing healthcare professionals' needs directly from the front lines. As a prolific contributor to his field, Estrada has authored numerous publications and presented at both national and international forums across various domains, including innovation, hospital management, and clinical management.
He played a pivotal role in founding the INEDIT Research Group at IGTP, serving as the group leader. Currently, Estrada directs the master's degree program in eHealth at La Salle Barcelona-Universitat Ramon Llull, further cementing his legacy as a leader in healthcare innovation and education.
Contact: oestrada(ELIMINAR)@gencat.cat
ORCID: 0000-0003-1414-5000
Team
Principal investigators
Daniel Moreno Martinez, PhD, FHEA(ELIMINAR)
Meritxell Davins Riu, PhD, MD(ELIMINAR)
Raül Zurita Badosa, PhD(ELIMINAR)
Raquel Escrich Navarro, PhD(ELIMINAR)
Josep Maria Ibañez Romaguera, PhD, MD(ELIMINAR)
Associate researchers
Laura Ricou Rios(ELIMINAR)
Mercè Bonjorn Dalm(ELIMINAR)
Guillem Hernandez Guillament(ELIMINAR)
Mireia Cano Izquierdo(ELIMINAR)
Maria Isabel Martinez Segura(ELIMINAR)
Laura Miró Mezquita(ELIMINAR)
Gerard Albreda Gil(ELIMINAR)
Eloi Querol Carranza(ELIMINAR)
Carles Miret
Pablo Alegre
Patricia Valero
Research lines
-
Technological innovation
-
Transformation and digital health
-
Health economics
Active projects
- MoniK project
- ASSIST project (Artificial Intelligence Scalable Solution for ST Myocardial Infarction)
- CRIPAP project: Hearing loss screening of a population area
- EIT Health - iDays
- EIT Health - Healthcare Transformation Academy
- Erasmus+ - 4D
- Erasmus+ - HEAL
- Cost-effectiveness study of the CardioMEMS device
- Cost-effectiveness study of the ProPCC program
- Cost-benefit analysis of the implementation of a vascular access team
- Economic impact of the implementation of a multidisciplinary diabetic foot clinic
Scientific publications
Highlighted publications
López Seguí F, Estrada Cuxart O, Mitjà I Villar O, Hernández Guillamet G, Prat Gil N, Maria Bonet J, Isnard Blanchar M, Moreno Millan N, Blanco I, Vilar Capella M, Català Sabaté M, Aran Solé A, Argimon Pallàs JM, Clotet B, Ara Del Rey J. A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona. Int J Environ Res Public Health. 2021 Jun 30;18(13):7028. DOI: 10.3390/ijerph18137028.
López Seguí F, Oyón Lerga U, Laguna Marmol L, Coll P, Andreu A, Meulbroek M, Lopez Casasnovas G, Estrada Cuxart O, Ara Rey J, Quiñones C, Perez F, Fernandez J, Rivero A, Ricou Rios L, Clotet B. Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona. PLoS ONE. 2023 Jan 17;18(1):e0277571. DOI: 10.1371/journal.pone.0277571.
López Seguí, F.; Navarrete Duran, J.M.; Tuldrà, A.; Sarquella, M.; Revollo, B.; Llibre, J.M.; Ara del Rey, J.; Estrada Cuxart, O.; Paredes Deirós, R.; Hernández Guillamet, G.; Clotet Sala, B.; Vidal Alaball, J.; Such Faro, P. Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings. Int. J. Environ. Res. Public Health. 2021 Jul 3;18(13):7129. DOI: 10.3390/ijerph18137129.
López, F.; Català, M.; Prats, C.; Estrada, O.; Oliva, I.; Prat, N.; Isnard, M.; Vallès, R.; Vilar, M.; Clotet, B.; Argimon, J.M.; Aran, A.; Ara, J. A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia. Vaccines (Basel). 2021 Dec 31;10(1):59. DOI: 10.3390/vaccines10010059.
Davins Riu M, Borràs Pérez X, Artigas Raventós V, Palomera Fanegas E, Serra Prat M, Alós Villacrosa J. Use of Telehealth as a New Model for Following Intermittent Claudication and Promoting Patient Expertise. Telemed J E Health. 2018 Oct;24(10):773-781. DOI: 10.1089/tmj.2017.0226.
Porras JG, Grau I, Davins M, Arenós R, Parra L, De Lourdes MI. ¿Qué hemos aprendido del COVID-19? ReMUE.c@t. 2020;7(1)13-13. Extracted from: https://www.remue.cat/view_document.php?tpd=2&i=16199
Torres M, Reixach E, Magem D, Gimenez E, Andrés E, Moreno-Martinez D, Espallargues M, en nom del grup de treball interinstitucional en innovació tecnològica per a la crisi de la COVID-19. PriTec-COVID-19: una eina per a la priorització de la innovació. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2021.
Gimenez E, Torres M, Moreno-Martinez D, Reixach E, Magem D, et al. (in press, 2022). Unmet needs for COVID-19 non-pharmacological innovative technology in Catalonia. Lessons learned for improvement of quality healthcare. IJQHC Communications.
Guillamet GH, Seguí FL, Vidal-Alaball J, López B. CauRuler: Causal irredundant association rule miner for complex patient trajectory modelling. Comput Biol Med. 2023 Feb 9;155:106636. DOI: 10.1016/j.compbiomed.2023.106636.
Roure S, López F, Oliva I, Pérez-Quílez O, March O, Chamorro A, Abad E, Muñoz IL, Castillo A, Soldevila L, Valerio L, Lozano M, Masnou H, Oliveira M, Cañas L, Gibrat M, Chuecos M, Montero JJ, Colmenares K, Falguera G, Bonet JM, Isnard M, Prat N, Estrada O, Clotet B, Vallès X. Schistosomiasis screening in non-endemic countries from a cost perspective: Knowledge gaps and research priorities. The case of African long-term residents in a Metropolitan Area, Spain. PLoS Negl Trop Dis. 2023 Apr 4;17(4):e0011221. DOI: 10.1371/journal.pntd.0011221.
Mas MÀ, Miralles R, Ulldemolins MJ, Garcia R, Gràcia S, Picaza JM, Navarro Fernández M, Rocabayera MA, Rivera M, Relaño N, Torres Asensio M, Laporta P, Morcillo C, Nadal L, Hervás R, Fuguet D, Alba C, Miralles Banqué N, Jiménez Panés S, Moreno Moreno M, Nogueras C, Manjón Navarro H, López R, Hernández G, López-Seguí F, Ríos LR, Pons A, Prat N, Ara Del Rey J, Estrada O. Evaluating Person-Centred Integrated Care to People with Complex Chronic Conditions: Early Implementation Results of the ProPCC Programme. International Journal of Integrated Care, 2023; 23(4): 18, 1-12. DOI: https://doi.org/10.5334/ijic.7585.
Additional information
Collaborative networks
XaRFA - Xarxa de Referència en Fabricació Additiva
Mission: Improve the transfer, valorization and internationalization of research around additive manufacturing developed by the Catalan R+D+I network.
Vision: With an eye on this milestone, the XaRFA Valorization and Transfer Program aims to become the link between the market and the Catalan research fabric in the field of 3D printing technology, positioning itself as the European benchmark in additive manufacturing and its applications.
Values: The actions of the XaRFA are based on the commitment to the institutions and member entities, the responsibility to generate shared and enriching synergies, and the generation of value to society with quality technological solutions.
Member entities: The XaRFA, led by CIM UPC (the UPC technology center leader in advanced production technologies), is made up of a total of 28 research groups from 14 institutions across Catalonia, including IGTP.
More information on the network can be found in the XaRFA website.
News
El cribratge de grups de risc per a la tuberculosi en països de baixa incidència: una estratègia rendible
Un estudi liderat per investigadors de l’IGTP, en col·laboració amb experts en economia de la salut de Can Ruti i de la UPF i l'Agència de Salut Pública de Barcelona, aporta noves recomanacions per optimitzar els programes de cribratge de la tuberculosi en països amb una baixa incidència. El treball, publicat a la revista Eurosurveillance, revisa diversos estudis per esbrinar si aquests programes dirigits a grups amb un major risc són efectius en termes econòmics.
Quatre projectes de l'IGTP finançats amb 1,7 milions d'euros pel Ministeri de Ciència i Innovació
L'Institut de recerca Germans Trias i Pujol (IGTP) ha obtingut finançament per desenvolupar quatre projectes presentats a la convocatòria competitiva "Proyectos de colaboración público privada" de l'Agència Estatal d'Investigació del Ministeri de Ciència i Innovació per un valor total de 1.706.019,92€.